Valuation: Edwards Lifesciences Corporation

Market Cap 51.78B 44.33B 41.36B 37.95B 71.32B 4,954B 72.72B 491B 191B 2,483B 194B 190B 8,220B P/E 2026 *
35.5x
P/E 2027 * 27.2x
Enterprise Value 48.15B 41.22B 38.46B 35.29B 66.32B 4,607B 67.62B 456B 178B 2,309B 181B 177B 7,644B EV / Sales 2026 *
7.12x
EV / Sales 2027 * 6.27x
Free-Float
86.96%
Yield 2026 *
-
Yield 2027 * -
1 day-2.65%
1 week-2.95%
Current month+4.37%
1 month+5.68%
3 months+8.27%
6 months+12.60%
Current year+5.37%
1 week 89.75
Extreme 89.75
93.25
1 month 81.16
Extreme 81.155
93.91
Current year 74.66
Extreme 74.66
96.29
1 year 72.3
Extreme 72.3
96.29
3 years 58.93
Extreme 58.93
96.29
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 2023-05-10
Director of Finance/CFO 43 2026-05-28
Chief Tech/Sci/R&D Officer 51 2025-08-31
Director TitleAgeSince
Chairman 69 2024-05-06
Director/Board Member 62 2015-02-09
Director/Board Member 58 2023-05-10
Date Insider Type Main position Quantity % Market Cap.
8/11/26 Fiscal year

Executive/Senior Manager

1,857 0.0003%
7/30/26 Sell

Executive/Senior Manager

-146 0.0000%
7/28/26 Fiscal year

Executive/Senior Manager

28,884 0.0050%
Change 5-day change 1-year change 3-year change Capi.($)
-2.65%-2.95%+10.37%+17.30% 51.78B
+2.28%+5.31%+26.83%+17.88% 232B
+2.09%+5.90%+2.13%-14.12% 152B
-5.84%-6.68%-22.06%+30.96% 132B
-5.08%-4.49%-53.45%-1.63% 71.55B
-0.34%+0.79%-17.10%-12.88% 51.75B
+0.57%+4.70%+31.22%+31.07% 44.14B
-2.68%-2.13%+36.38%+49.89% 39.76B
-0.75%+0.37%+0.26%+8.34% 33.45B
-0.96%+0.75%-20.97%+37.89% 32.95B
Average -1.00%+0.49%-0.64%+16.47% 84.15B
Weighted average by Cap. -0.87%+1.36%+1.90%+13.18%

Financials

2026 *2027 *
Net sales 6.76B 5.79B 5.4B 4.95B 9.31B 647B 9.49B 64.06B 24.97B 324B 25.38B 24.83B 1,073B 7.43B 6.36B 5.93B 5.45B 10.23B 711B 10.43B 70.41B 27.45B 356B 27.89B 27.29B 1,179B
Net income 1.44B 1.23B 1.15B 1.05B 1.98B 137B 2.02B 13.6B 5.3B 68.82B 5.39B 5.27B 228B 1.9B 1.62B 1.52B 1.39B 2.61B 181B 2.66B 17.97B 7.01B 90.95B 7.12B 6.97B 301B
Net Debt -3.63B -3.11B -2.9B -2.66B -5B -347B -5.1B -34.41B -13.41B -174B -13.63B -13.34B -576B -5.19B -4.45B -4.15B -3.81B -7.16B -497B -7.3B -49.23B -19.19B -249B -19.5B -19.08B -825B
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
26-08-20 $89.83 -2.65% 2,638,021
26-08-19 $92.28 +1.43% 3,406,151
26-08-18 $90.98 +0.19% 2,762,349
26-08-17 $90.81 -0.86% 2,246,351
26-08-14 $91.60 -1.04% 2,856,892
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
89.83USD
Average target price
100.96USD
Spread / Average Target
+12.39%

Quarterly revenue - Rate of surprise